Acquisition by Allen Jim L. of 50000 shares of Biocardia at 3.0 subject to Rule 16b-3

BCDA Stock  USD 1.97  0.13  7.07%   
About 68 percent of all Biocardia's investors are curious in acquiring. The analysis of the overall investor sentiment regarding Biocardia suggests that a large number of traders are confidant. The current market sentiment, together with Biocardia's historical and current headlines, can help investors time the market. In addition, many technical investors use Biocardia stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Biocardia Director. Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
Acquisition of 50000 warrant (right to buy) at 3.0 of Biocardia by Allen Jim L. on 9th of September 2024. This event was filed by Biocardia with SEC on 2024-09-30. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Biocardia's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Biocardia's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Biocardia Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Biocardia can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Biocardia Fundamental Analysis

We analyze Biocardia's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biocardia using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biocardia based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

EBITDA

EBITDA Comparative Analysis

Biocardia is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Biocardia Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biocardia stock to make a market-neutral strategy. Peer analysis of Biocardia could also be used in its relative valuation, which is a method of valuing Biocardia by comparing valuation metrics with similar companies.

Peers

Biocardia Related Equities

ABVCABVC Biopharma   6.12   
0%
56.0%
INDPIndaptus Therapeutics   5.62   
0%
51.0%
MLYSMineralys Therapeutics,   4.31   
0%
39.0%
RZLTRezolute   3.78   
0%
34.0%
ERASErasca   3.67   
0%
33.0%
FBRXForte Biosciences   3.64   
0%
33.0%
ADAGAdagene   1.99   
0%
18.0%
ACRVAcrivon Therapeutics,   0.30   
0%
2.0%
ANTXAN2 Therapeutics   0.79   
7.0%
0%
AVTEAerovate Therapeutics   1.17   
10.0%
0%
KTTAPasithea Therapeutics   1.50   
13.0%
0%
NGENFNervGen Pharma   3.70   
34.0%
0%
PTIXProtagenic Therapeutics   9.09   
84.0%
0%
ANEBAnebulo Pharmaceuticals   10.81   
100.0%
0%

Complementary Tools for Biocardia Stock analysis

When running Biocardia's price analysis, check to measure Biocardia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocardia is operating at the current time. Most of Biocardia's value examination focuses on studying past and present price action to predict the probability of Biocardia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biocardia's price. Additionally, you may evaluate how the addition of Biocardia to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges